Particle.news

Download on the App Store

FDA Approves New Non-Hormonal Treatment for Hot Flashes

Image
Image
Astellas Pharma's logo is pictured at its headquarters in Tokyo, Japan, December 3, 2019.   REUTERS/Kim Kyung-Hoon/File Photo

Overview

  • The US Food and Drug Administration approved a non-hormonal therapy called Veozah to treat hot flashes associated with menopause.
  • Veozah works by blocking a chemical in the brain that regulates nerve cell activity.
  • Veozah can be used to relieve moderate to severe menopause symptoms like hot flashes and night sweats.
  • As a non-hormonal treatment, Veozah provides an alternative to hormone replacement therapy for menopausal women.
  • The approval of Veozah gives women experiencing menopause a new option for relief from their symptoms.